Navigation Links
Healionics Awarded $900k Grant from NIH
Date:9/20/2012

SEATTLE, Sept. 20, 2012 /PRNewswire/ -- Healionics Corporation received a $909,165 Phase II Small Business Innovation Research (SBIR) grant award from the National Institute of General Medical Sciences division of the National Institutes of Health (NIH) for preclinical studies to advance STARcuffTM, a STAR® Biomaterial-based anti-infective exit site sleeve for hemodialysis catheters. Andrew Marshall, Healionics' Chief Technology Officer, is the Principal Investigator for this research project.

(Logo: http://photos.prnewswire.com/prnh/20120920/SF77922LOGO)

Titled, "Anti-Infective Dermal Integration Sleeves for Needle-Free Dialysis Access Devices," the award provides funding to refine the STARcuff anti-infection technology and broaden its range of device applicability.

Hemodialysis patients are at high risk for life-threatening bloodstream infections. Treatment of catheter-associated infections at $35,000 to $60,000 per episode exceeds the yearly cost of routine dialysis sessions. Nearly half of these infections proceed extraluminally via the exit site.

"Catheters loaded with active antimicrobial agents or antiseptics are a controversial option for chronic dialysis patients due to the serious threat of microbial resistance," says Marshall. "STARcuff is an attractive approach because it can potentially provide long-term protection against infection without any active agents."

More information about SBIR grants from the National Institutes of Health can be found at http://grants.nih.gov/grants/funding/sbir.htm.

About Healionics Corporation
Healionics develops and manufactures STAR® Biomaterials for implanted medical devices. The precisely controlled pore structure of the innovative STAR technology induces a favorable integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and longevity.  The company has two medical device subsidiaries: iSTAR Medical and qSTAR Medical.

Websites:
     www.healionics.com 
     www.istarmed.com 
     www.qstarmed.com


'/>"/>
SOURCE Healionics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
2. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
3. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
4. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
5. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
6. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
7. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
8. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
9. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
10. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
11. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... 2017 Three Tru-D SmartUVC robots have arrived at ... . Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 ... environmental services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at ... "Although the BAACH has a very low ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
(Date:7/27/2017)... Ind., July 27, 2017  Zimmer Biomet Holdings, Inc. ... quarter ended June 30, 2017.  The Company reported second ... 1.1% over the prior year period, and an increase ... 240 basis points of contribution from the LDR Holding ... the second quarter of 2016, or 0.3% on a ...
Breaking Medicine Technology:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... FCPX LUT ... Editors can quickly and easily add washed color grades to footage. A LUT ... LUT changes every pixel’s color to the corresponding color indicated by the table. This ...
(Date:8/21/2017)... ... August 21, 2017 , ... Marathon running has surged ... country. , Outdoor running increases exposure to ultraviolet radiation, a carcinogen that promotes ... melanoma, and only half may be adequately protecting themselves with proper clothing and ...
(Date:8/21/2017)... ... ... PIXACORE , an independent full-service agency with a decade of experience ... year by MM&M. , This is the first time PIXACORE has made the Top ... PIXACORE’s newfound recognition reflects its steady trajectory of growth and recent strategic transformation. ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... August 20, 2017 , ... ... HIPAA ComplyPAK™ Compliance Management System has assisted multiple clients in successfully passing ... Accountants, Service Organization Control Level 2 (AICPA SOC Level 2), and State Data ...
Breaking Medicine News(10 mins):